Recent Finacing
Recent Raise
Cavion is a clinical-stage biotech developing T-type (Cav3) calcium channel modulators, including CX-8998 for essential tremor, and co-sponsoring a glioblastoma trial combining mibefradil with hypofractionated radiotherapy.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors